209 related articles for article (PubMed ID: 23824782)
1. Diagnostic usefulness of an amino acid tracer, α-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies.
Nishii R; Higashi T; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Motoyama H; Kawakami K; Nakaoku T; Nohara J; Okamura M; Watanabe T; Nakatani K; Nagamachi S; Tamura S; Kawai K; Kobayashi M
Ann Nucl Med; 2013 Nov; 27(9):808-21. PubMed ID: 23824782
[TBL] [Abstract][Full Text] [Related]
2. (11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET.
Arimoto MK; Higashi T; Nishii R; Kagawa S; Takahashi M; Kishibe Y; Yamauchi H; Ishitoya S; Oonishi H; Nakamoto Y; Togashi K
Ann Nucl Med; 2016 Oct; 30(8):553-62. PubMed ID: 27329084
[TBL] [Abstract][Full Text] [Related]
3. Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging.
Nishii R; Higashi T; Kagawa S; Arimoto M; Kishibe Y; Takahashi M; Yamada S; Saiki M; Arakawa Y; Yamauchi H; Okuyama C; Hojo M; Munemitsu T; Sawada M; Kobayashi M; Kawai K; Nagamachi S; Hirai T; Miyamoto S
Contrast Media Mol Imaging; 2018; 2018():1292746. PubMed ID: 30026674
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of [11C] methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo.
Sutinen E; Jyrkkiö S; Grönroos T; Haaparanta M; Lehikoinen P; Någren K
Eur J Nucl Med; 2001 Jul; 28(7):847-54. PubMed ID: 11504081
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
7. Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.
Pauls S; Buck AK; Halter G; Mottaghy FM; Muche R; Bluemel C; Gerstner S; Krüger S; Glatting G; Sunder-Plassmann L; Möller P; Brambs HJ; Reske SN
Mol Imaging Biol; 2008; 10(2):121-8. PubMed ID: 18204955
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Bar-Shalom R; Kagna O; Israel O; Guralnik L
Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Yudistiro R; Arisaka Y; Tokue A; Nakajima T
BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
[TBL] [Abstract][Full Text] [Related]
10. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
[TBL] [Abstract][Full Text] [Related]
11. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
12. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest.
Bangerter M; Kotzerke J; Griesshammer M; Elsner K; Reske SN; Bergmann L
Acta Oncol; 1999; 38(6):799-804. PubMed ID: 10522771
[TBL] [Abstract][Full Text] [Related]
15. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of FDG uptake in pulmonary hila with FDG PET/CT and contrast-enhanced CT in patients with thoracic and non-thoracic tumors.
Gedik GK; Kara PO; Kara T; Sari O; Kara F
Ann Nucl Med; 2010 Oct; 24(8):593-9. PubMed ID: 20665251
[TBL] [Abstract][Full Text] [Related]
17. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
18. Estimation of Tumor Volumes by 11C-MeAIB and 18F-FDG PET in an Orthotopic Glioblastoma Rat Model.
Halle B; Thisgaard H; Hvidsten S; Dam JH; Aaberg-Jessen C; Thykjær AS; Høilund-Carlsen PF; Schulz MK; Andersen C; Kristensen BW
J Nucl Med; 2015 Oct; 56(10):1562-8. PubMed ID: 26229144
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
